Ignite Creation Date:
2024-05-06 @ 7:39 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06086288
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-10-17
First Post:
2023-09-26
Brief Title:
Study of PembrolizumAb combiNeD With Cisplatin or carbOplatin and Etoposide in Treatment naïve Advanced meRkel Cell cArcinoma MCC
Sponsor:
Organization:
Fondazione IRCCS Istituto Nazionale dei Tumori Milano